Oncolytics Biotech Stock Price on December 11, 2024

ONC Stock  CAD 1.20  0.02  1.64%   
Below is the normalized historical share price chart for Oncolytics Biotech extending back to November 08, 1999. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oncolytics Biotech stands at 1.20, as last reported on the 12th of December 2024, with the highest price reaching 1.23 and the lowest price hitting 1.18 during the day.
200 Day MA
1.4357
50 Day MA
1.5076
Beta
1.506
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Oncolytics Stock, it is important to understand the factors that can impact its price. Oncolytics Biotech maintains Sharpe Ratio (i.e., Efficiency) of -3.0E-4, which implies the firm had a -3.0E-4% return per unit of risk over the last 3 months. Oncolytics Biotech exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncolytics Biotech's Risk Adjusted Performance of 0.0084, coefficient of variation of (359,611), and Variance of 26.59 to confirm the risk estimate we provide.
  
At this time, Oncolytics Biotech's Common Stock Shares Outstanding is very stable compared to the past year. As of the 12th of December 2024, Other Stockholder Equity is likely to grow to about 42.9 M, while Total Stockholder Equity is likely to drop about 17.8 M. . At this time, Oncolytics Biotech's Price Book Value Ratio is very stable compared to the past year. As of the 12th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.96, while Price To Sales Ratio is likely to drop 66.83. Oncolytics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -3.0E-4

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsONC

Estimated Market Risk

 5.24
  actual daily
46
54% of assets are more volatile

Expected Return

 0.0
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average Oncolytics Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncolytics Biotech by adding Oncolytics Biotech to a well-diversified portfolio.
Price Book
10.3821
Book Value
0.37
Enterprise Value
75.5 M
Enterprise Value Ebitda
(2.45)
Shares Float
73.8 M

Oncolytics Biotech Valuation on December 11, 2024

It is possible to determine the worth of Oncolytics Biotech on a given historical date. On December 11, 2024 Oncolytics was worth 1.26 at the beginning of the trading date compared to the closed value of 1.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncolytics Biotech stock. Still, in general, we apply an absolute valuation method to find Oncolytics Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncolytics Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncolytics Biotech's related companies.
 Open High Low Close Volume
  1.28    1.28    1.21    1.23    91,588  
12/11/2024
  1.26    1.26    1.19    1.22    130,021  
  1.21    1.23    1.18    1.20    123,141  
Backtest Oncolytics Biotech  |  Oncolytics Biotech History  |  Oncolytics Biotech Valuation   PreviousNext  
Open Value
1.26
1.22
Closing Value
16.97
Upside

Oncolytics Biotech Trading Date Momentum on December 11, 2024

On December 12 2024 Oncolytics Biotech was traded for  1.20  at the closing time. The maximum traded price for the trading interval was 1.23  and the lowest daily price was  1.18 . The daily volume was recorded at 123.1 K. The volume of trading on 12th of December 2024 played a part in the next trading day price drop. The trading delta at closing time to the next closing price was 1.64% . The trading delta at closing time to the closing price today is 0.82% .

Oncolytics Biotech Fundamentals Correlations and Trends

By evaluating Oncolytics Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncolytics Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncolytics financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oncolytics Biotech Stock history

Oncolytics Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncolytics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncolytics Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncolytics Biotech stock prices may prove useful in developing a viable investing in Oncolytics Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding67.6 M71 M
Net Loss-22.4 M-23.5 M

Oncolytics Biotech Quarterly Net Working Capital

15.25 Million

Oncolytics Biotech Stock Technical Analysis

Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Oncolytics Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oncolytics Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oncolytics Biotech Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Oncolytics Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oncolytics Biotech December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how Oncolytics Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncolytics Biotech shares will generate the highest return on investment. By undertsting and applying Oncolytics Biotech stock market strength indicators, traders can identify Oncolytics Biotech entry and exit signals to maximize returns

Oncolytics Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Oncolytics Biotech's price direction in advance. Along with the technical and fundamental analysis of Oncolytics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncolytics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Oncolytics Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncolytics Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncolytics Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncolytics Biotech Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Please note, there is a significant difference between Oncolytics Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncolytics Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncolytics Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.